Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms.
about
Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activityEvidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Immunostimulatory Gene Therapy Using Oncolytic Viruses as VehiclesCancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesMyeloid-derived suppressor cells in the tumor microenvironment: expect the unexpectedRandomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic AdenocarcinomaRanitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses.The oncolytic virus, pelareorep, as a novel anticancer agent: a review.All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy.Quantitative Temporal in Vivo Proteomics Deciphers the Transition of Virus-Driven Myeloid Cells into M2 Macrophages.Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.The effects of oncolytic reovirus in canine lymphoma cell lines.Surface modulatable nanocapsids for targeting and tracking toward nanotheranostic delivery.Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses.Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells.Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model.Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus.Review: Oncolytic virotherapy, updates and future directions.Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas.Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer.A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209.Current understanding of reovirus oncolysis mechanisms.Clostridium novyi-NT in cancer therapy
P2860
Q26750568-0F460866-AABC-4431-B735-BD19BE45F342Q26775030-9374D1C9-BFC5-41D9-B607-2A1EDEC66D0AQ26777403-5C70321B-4573-4D49-A83B-940B6986322FQ26863779-A0D1A8A0-576E-4F88-87AE-01475B75B901Q28084627-B4927E7A-B594-49F1-887E-D86503D29353Q37043514-2C06872D-E075-4946-BD6F-5FC5F3A55B63Q37222105-78052489-F270-488C-A528-367650E06AF0Q38237657-36A6088C-6CE9-4FEA-AB80-082CB0F8B010Q38360781-077BB8E6-46B1-4878-AA14-7253A3F77D12Q38563884-F52D0F38-BF77-4180-A4AC-6DA24C76F8EBQ38646337-A5EADC23-BBF2-4BC0-9E27-13B4327F1038Q38646993-A4BD9DDC-6F5E-4238-8493-7C7917410D6FQ38947511-9AB30D21-7832-4671-93C4-5E186F006EF7Q38950048-1576BE33-0738-4DEE-B550-DBF9007EE82EQ39244891-951DB98B-EE58-4886-9D31-A1B2D44E4B45Q39389295-748190A9-3CF1-4B1A-8144-034BBADA7134Q40056618-AA785006-62A9-4D1E-A42B-FA236D521CCFQ41137180-06BE4D43-B7A1-4608-BA70-CD0A4EB9DF9CQ47160989-152697E7-3C63-4233-A590-549F21725D02Q47266341-E8E6A4FD-7112-432D-90B2-295DA7D1E786Q50544084-EACD4AE3-E8F6-4919-A990-78A07066DB50Q53706001-B8B46B17-E6E1-4EBF-A278-45A373AD6519Q55427397-FD51CF9D-4F6C-4E9B-ABAE-EFB7DECE9664Q56566095-9AFB0E17-03AD-4C7F-A46C-9C16D037F8EC
P2860
Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Gemcitabine enhances the effic ...... mour immunological mechanisms.
@en
Gemcitabine enhances the effic ...... mour immunological mechanisms.
@nl
type
label
Gemcitabine enhances the effic ...... mour immunological mechanisms.
@en
Gemcitabine enhances the effic ...... mour immunological mechanisms.
@nl
prefLabel
Gemcitabine enhances the effic ...... mour immunological mechanisms.
@en
Gemcitabine enhances the effic ...... mour immunological mechanisms.
@nl
P2093
P2860
P356
P1476
Gemcitabine enhances the effic ...... mour immunological mechanisms.
@en
P2093
D Clements
R Dielschneider
P2860
P2888
P356
10.1038/BJC.2013.695
P407
P577
2013-11-26T00:00:00Z